The GEPIA database showed that HDAC1/2/3/4/5/7/9/10/11 mRNA expression levels were significantly associated with glioma patient prognosis and could, therefore, be exploited as biomarkers for the prediction of glioma patient survival. The gene discussed is HDAC1; the disease is glioma.